Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-23

FDA Approved: LINEZOLID — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for LINEZOLID by Ascend Laboratories, LLC. The action approves changes to the product's labeling for Linezolid.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linezolid (Linezolid)

Snippet

SUPPL AP for LINEZOLID (LINEZOLID)